Literature DB >> 17293739

Prehypertension as a risk factor for cardiovascular diseases.

M Fareed K Suri1, Adnan I Qureshi.   

Abstract

Systolic blood pressure (BP) of less than 140 mm Hg and diastolic BP of less than 90 mm Hg were previously considered normal. However, there was some evidence that even BP in the high reference range was associated with an increased risk of cardiovascular disease. The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure defined a new BP category "prehypertension" for systolic and diastolic BP: 120 to 139 mm Hg and 85 to 89 mm Hg, respectively. This new category is a continuum to hypertension and is a risk factor for cardiovascular disease. The progression of prehypertension to hypertension can be delayed or may be prevented by lifestyle changes.

Entities:  

Mesh:

Year:  2006        PMID: 17293739     DOI: 10.1097/00005082-200611000-00012

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  10 in total

1.  The burden, management rates and influencing factors of high blood pressure in a Chinese rural population: the Rural Diabetes, Obesity and Lifestyle (RuralDiab) study.

Authors:  Xiaotian Liu; Yuqian Li; Ying Guo; Linlin Li; Kaili Yang; Ruihua Liu; Zhenxing Mao; Ronghai Bie; Chongjian Wang
Journal:  J Hum Hypertens       Date:  2018-02-13       Impact factor: 3.012

2.  PTSD symptom clusters and cardiovascular responses to stress: Reactivity and recovery.

Authors:  Sharon Y Lee; Crystal L Park; Burak T Cilhoroz; Linda S Pescatello
Journal:  J Psychosom Res       Date:  2022-07-29       Impact factor: 4.620

3.  Elevated resting blood pressure augments autonomic imbalance in posttraumatic stress disorder.

Authors:  Ida T Fonkoue; Seth D Norrholm; Paul J Marvar; Yunxiao Li; Melanie L Kankam; Barbara O Rothbaum; Jeanie Park
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-10-10       Impact factor: 3.619

4.  The prevalence of pre-hypertension and hypertension in an Iranian urban population.

Authors:  Ahmad Khosravi; Mohammad Hassan Emamian; Mohammad Shariati; Hassan Hashemi; Akbar Fotouhi
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-23

5.  Prehypertension and incidence of cardiovascular disease: a meta-analysis.

Authors:  Yuli Huang; Sheng Wang; Xiaoyan Cai; Weiyi Mai; Yunzhao Hu; Hongfeng Tang; Dingli Xu
Journal:  BMC Med       Date:  2013-08-02       Impact factor: 8.775

6.  Prevalence and Correlates of Prehypertension and Hypertension among Adults in Northeastern China: A Cross-Sectional Study.

Authors:  Guang Yang; Yue Ma; Shibin Wang; Yingying Su; Wenwang Rao; Yingli Fu; Yaqin Yu; Changgui Kou
Journal:  Int J Environ Res Public Health       Date:  2015-12-25       Impact factor: 3.390

7.  Prevalence and Risk Factors of Prehypertension and Hypertension in Southern China.

Authors:  Lihua Hu; Xiao Huang; Chunjiao You; Juxiang Li; Kui Hong; Ping Li; Yanqing Wu; Qinhua Wu; Huihui Bao; Xiaoshu Cheng
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

8.  Trends of blood pressure levels and management in Västerbotten County, Sweden, during 1990-2010.

Authors:  Nawi Ng; Bo Carlberg; Lars Weinehall; Margareta Norberg
Journal:  Glob Health Action       Date:  2012-07-30       Impact factor: 2.640

9.  The Epidemiology of Hypertension in Uganda: Findings from the National Non-Communicable Diseases Risk Factor Survey.

Authors:  David Guwatudde; Gerald Mutungi; Ronald Wesonga; Richard Kajjura; Hafisa Kasule; James Muwonge; Vincent Ssenono; Silver K Bahendeka
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  The burden of hypertension in sub-Saharan Africa: a four-country cross sectional study.

Authors:  David Guwatudde; Joan Nankya-Mutyoba; Robert Kalyesubula; Carien Laurence; Clement Adebamowo; IkeOluwapo Ajayi; Francis Bajunirwe; Marina Njelekela; Faraja S Chiwanga; Todd Reid; Jimmy Volmink; Hans-Olov Adami; Michelle D Holmes; Shona Dalal
Journal:  BMC Public Health       Date:  2015-12-05       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.